This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n6http://linked.opendata.cz/resource/drugbank/drug/DB07072/identifier/chemspider/
n14http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://linked.opendata.cz/resource/drugbank/drug/DB07072/identifier/pdb/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n7http://linked.opendata.cz/resource/drugbank/drug/DB07072/identifier/pubchem-compound/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n8http://linked.opendata.cz/resource/drugbank/drug/DB07072/identifier/pubchem-substance/
n9http://linked.opendata.cz/resource/drugbank/drug/DB07072/identifier/drugbank/

Statements

Subject Item
n2:DB07072
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n12:DB07072 n14:DB07072
dcterms:title
(1S,2R,5S)-5-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-2-(2,4,5-TRIFLUOROPHENYL)CYCLOHEXANAMINE
adms:identifier
n6:9713772 n7:11538992 n8:99443543 n9:DB07072 n10:417
n3:IUPAC-Name
n4:271B46FF-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4705-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4704-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4701-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4702-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4703-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B46FD-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B46FE-363D-11E5-9242-09173F13E4C5 n4:271B46FB-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B46FC-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B470B-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B470C-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4706-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4707-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4709-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4708-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B470A-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4710-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4712-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4713-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B470F-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B470E-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4711-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4700-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B470D-363D-11E5-9242-09173F13E4C5